Investment
Features
FeesSafety
Academy
More
Pluang+

Compare NiSource Inc Common Stock (NI) vs Vaxcyte Inc. Common Stock (PCVX) Price & Performance

NiSource Inc Common StockTrade
Vaxcyte Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

NiSource Inc Common Stock vs Vaxcyte Inc. Common Stock — how do they compare? NiSource Inc Common Stock trades at $41.35 (market cap $19.90B), while Vaxcyte Inc. Common Stock trades at $67.27 (market cap $10.51B). The key difference: NiSource Inc Common Stock is the larger of the two by market cap, and NiSource Inc Common Stock pays a 2.89% dividend while Vaxcyte Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold NiSource Inc Common Stock for 6 Days and Vaxcyte Inc. Common Stock for 0 Days on average.

NIPCVX
Market Cap
$19.90B$10.51B
Volume
3,295,5802,644,694
Sector
UtilitiesHealth
52-Week High
$49.08$73.82
52-Week Low
$39.00$40.32
Typical Hold Time
6 Days0 Days
Enterprise Value
$37.23B$9.14B
Dividend Yield
2.89%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

NiSource Inc Common Stock

NiSource (NI) trades at $41.49, up 0.63% today, with a bullish technical signal and strong analyst support. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 28, 2026. Fundamentals show solid profitability with a 13.15% net income margin and a P/E of 22.07. Recent news highlights dividend declarations and institutional buying interest, though the stock faces headwinds from storm recovery costs and interest rate sensitivity.

The outlook remains positive given analyst consensus with a $49.57 price target and 73% buy ratings. Key opportunities include data center demand growth and regulatory support, while risks involve volatile cash flows, high debt levels, and potential earnings pressure from operational disruptions. Investors should weigh the stable dividend yield against execution risks in a rising rate environment.

Vaxcyte Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

NI

No sentiment data available yet.

PCVX
100% Buy0% Sell
Avg holding period · 0 Days

About NiSource Inc Common Stock

NiSource is an energy holding company whose regulated subsidiaries provide natural gas and electricity services. Its business is organized around gas distribution and electric operations in the United States.

Read more on NI →

About Vaxcyte Inc. Common Stock

Vaxcyte, Inc. is a clinical-stage vaccine company that engineers protein-based vaccines to prevent bacterial diseases such as invasive pneumococcal disease, using its proprietary cell-free protein synthesis platform to develop candidates including the pneumococcal conjugate vaccines VAX-31 and VAX-24.

Read more on PCVX →